CELL SIGNALING TECHNOLOGY search Cell Signaling Technology RPS6KB1 products
includes other brands or spellings
|
| ih, wb | | Cell Signaling Technology anti-S6K and anti-phospho-S6K (Thr389) antibodies were used in paraffin sections and protein from human hepatocellular tumors and in immunohistochemistry, western blot to study the role of mTOR and S6K in hepatocellular carcinoma. |
| ih | | Cell Signaling antibody that specifically recognize phosphorylated p70S6K at Thr389 was used in immunohistochemistry to study the expression of p70S6K in human TSC renal pathology. |
| ip, wb | | Cell Signaling Technology antibodies against S6-kinasen and phosphorylated S6-kinase (Thr-389) was used in western blot and immunoprecipitation to study the critical role of the mTOR-dependent suppression of protein phosphatase 2A for phospholipase D survival signals in human breast cancer cells. |
| wb | | Cell Signaling Technology anti-phospho-T389-S6K antibody was used in western blot to study amino acids mediate mTOR activation by signaling through class 3 PI3K, hVps34. |
| wb | | Cell Signaling Technology anti-p70S6k and phospho-p70S6k antibody was used in western blot to study that resveratrol increases serine15-phosphorylated but transcriptionally impaired p53 and induces a reversible DNA replication block in serum-activated vascular smooth muscle cells. |
| wb | | Cell Signaling Biotechnology anti-p70S6 kinase and phosphorylated p70S6 kinase (Thr421/Ser424) antibody was used in western blot to detect p70S6 kinase and phosphorylated p70S6 kinase in the bovine aortic endothelial cells transfected with the adenoviral constructs for human SOD1, SOD2, and catalase. |
| wb | | Cell Signaling Technology anti-phospho-p70S6 kinase antibody was used in western blot to detect phospho-p70S6 kinase in 293T cells transfected with human TSC2 and TSC1. |
| wb | | Cell Signaling Technology anti-p70S6K and phospho-p70S6K antibody was used in western blot to detect p70S6K and phospho-p70S6K in U251 human glioma cells treated in normoxic or hypoxic conditions in the presence or absence of TPT, LY294002, and rapamycin. |
| wb | | Cell Signaling anti-phospho-p70S6K (Thr-389) antibody (catalog number 9205) was used in human LNCaP cells and in western blot to study the role of epidermal growth factor in transforming growth factor beta signaling and growth suppression. |
| wb | | Cell Signaling Technologies phospho-p70S6K Thr389 antibody was used in western blot to study the effect of VIIa/tissue factor interaction. |
| wb | | Cell Signalling Technology anti- (phospho S6K1 Thr-389) antibody was used in western blot to study ribosomal S6 kinase 2 actvity regulation. |
| wb | | Cell Signaling phospho-S6K1 (Thr389) antibody was used in western blot to investigate the repression of RNA polymerase I transcription by PTEN. |
| wb | | Cell Signaling Technology anti-phospho-p70 S6 kinase (Thr389) antibody was used in western blot to study cell survival by GLP-2R signaling. |
| wb | | Cell Signaling anti-S6K1 and anti-phospho-S6K1-T389 antibodies were used in western blot to investigate the interactin among Akt, mTOR, and AMPK. |
| wb | | Cell Signaling rabbit anti-phospho-p70S6K antibodies (Thr389 and Ser421/Thr424) were used in western blot to study the role of DGK in the mTOR pathway. |
| wb | | Cell Signaling rabbit polyclonal Thr421/Ser424-phosphorylated p70S6K antibody wase used in western blot to investigate the down-regulation of phospholipase D2 in the EWS-Fli1-knocked down TC-135 cells. |
| wb | | Cell Signaling antiphospho-S6K1 antibody was used in western blot to identify S6 Kinase 1 as a mTOR-phosphorylating Kinase. |
SANTA CRUZ BIOTECHNOLOGY search Santa Cruz Biotechnology RPS6KB1 products
includes other brands or spellings
|
| wb | | Santa Cruz Biotechnology polyclonal rabbit anti-p70 S6 kinase antibody was used in western blot to study the role of h1-calponin in the regulation of differentiation of AR42J cells into insulin-producing cells at least partly through modulating ARE transcriptional activity. |
| wb | | Santa Cruz Biotechnology p70S6K antibody was used in western blot to study the effect of VIIa/tissue factor interaction. |
| wb | | Santa Cruz Biotechnology mouse anti-p70S6K antibody was used in western blot to study the role of DGK in the mTOR pathway. |
BD BIOSCIENCES search BD Biosciences RPS6KB1 products
includes other brands or spellings
|
| wb | | BD Transduction p70 S6 Kinase antibody was tested in western blot by Abminer. |
Articles Reviewed |
| 1. Bernardo Yusta et al. Glucagon-like peptide-2 receptor activation engages bad and glycogen synthase kinase-3 in a protein kinase A-dependent manner and prevents apoptosis following inhibition of phosphatidylinositol 3-kinase. 2002 |
| 2. Henri H Versteeg et al. VIIa/tissue factor interaction results in a tissue factor cytoplasmic domain-independent activation of protein synthesis, p70, and p90 S6 kinase phosphorylation. 2002 |
| 3. Heidi L Kenerson et al. Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors. 2002 |
| 4. Tomoaki Morioka et al. Role of H1-calponin in pancreatic AR42J cell differentiation into insulin-producing cells. 2003 |
| 5. Ursula G B Haider et al. Resveratrol increases serine15-phosphorylated but transcriptionally impaired p53 and induces a reversible DNA replication block in serum-activated vascular smooth muscle cells. 2003 |
| 6. Sopheap Phin et al. Mutational analysis of ribosomal S6 kinase 2 shows differential regulation of its kinase activity from that of ribosomal S6 kinase 1. 2003 |
| 7. Ming-Hui Zou et al. Activation of 5'-AMP-activated kinase is mediated through c-Src and phosphoinositide 3-kinase activity during hypoxia-reoxygenation of bovine aortic endothelial cells. Role of peroxynitrite. 2003 |
| 8. Ariel F Castro et al. Rheb binds tuberous sclerosis complex 2 (TSC2) and promotes S6 kinase activation in a rapamycin- and farnesylation-dependent manner. 2003 |
| 9. Annamaria Rapisarda et al. Topoisomerase I-mediated inhibition of hypoxia-inducible factor 1: mechanism and therapeutic implications. 2004 |
| 10. Fikret Sahin et al. mTOR and P70 S6 kinase expression in primary liver neoplasms. 2004 |
| 11. Antonia Avila-Flores et al. Modulation of the mammalian target of rapamycin pathway by diacylglycerol kinase-produced phosphatidic acid. 2005 |
| 12. Marina K Holz et al. Identification of S6 kinase 1 as a novel mammalian target of rapamycin (mTOR)-phosphorylating kinase. 2005 |
| 13. Satoshi Nozawa et al. Inhibition of platelet-derived growth factor-induced cell growth signaling by a short interfering RNA for EWS-Fli1 via down-regulation of phospholipase D2 in Ewing sarcoma cells. 2005 |
| 14. Annett Hahn-Windgassen et al. Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity. 2005 |
| 15. Cheng Zhang et al. PTEN represses RNA Polymerase I transcription by disrupting the SL1 complex. 2005 |
| 16. Li Hui et al. mTOR-dependent suppression of protein phosphatase 2A is critical for phospholipase D survival signals in human breast cancer cells. 2005 |
| 17. Takahiro Nobukuni et al. Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 3OH-kinase. 2005 |
| 18. Kyung Song et al. Novel permissive role of epidermal growth factor in transforming growth factor beta (TGF-beta) signaling and growth suppression. Mediation by stabilization of TGF-beta receptor type II. 2006 |
| 19. Sylvia M Major et al. AbMiner: a bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies. 2006 |